scispace - formally typeset
V

Vinay Chaudhry

Researcher at Johns Hopkins University

Publications -  88
Citations -  7182

Vinay Chaudhry is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Peripheral neuropathy & Multifocal motor neuropathy. The author has an hindex of 41, co-authored 87 publications receiving 6512 citations. Previous affiliations of Vinay Chaudhry include Columbia University & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Rhabdomyolysis: an evaluation of 475 hospitalized patients.

Giorgia Melli, +2 more
- 01 Nov 2005 - 
TL;DR: Exogenous toxins were the most common cause of rhabdomyolysis, with illicit drugs, alcohol, and prescribed drugs responsible for 46%.
Journal ArticleDOI

The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

Brent G. Petty, +8 more
- 01 Aug 1994 - 
TL;DR: Results indicate that systemically administered rhNGF exerts a characteristic and reproducible biological effect in healthy subjects at very low doses and in a dose‐dependent manner.
Journal ArticleDOI

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, +623 more
- 01 Dec 2017 - 
TL;DR: A phase 3, randomised, double-blind, placebo-controlled, multicentre study in 76 hospitals and specialised clinics across North America, Latin America, Europe, and Asia to assess the efficacy and safety of eculizumab in patients with refractory myasthenia gravis.
Journal ArticleDOI

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies

Vinay Chaudhry, +5 more
- 01 Mar 1994 - 
TL;DR: It is concluded that sensory–motor neuropathy is a frequent dose‐dependent toxicity of combined cisplatin and taxol use and is likely to become the major dose‐limiting toxicity of taxol–cisplatin combination chemotherapy when higher doses of these agents are administered with granulocyte‐colony stimulating factor.
Journal ArticleDOI

Evidence-based guideline update: Plasmapheresis in neurologic disorders Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Irene Cortese, +5 more
- 18 Jan 2011 - 
TL;DR: There is insufficient evidence to support or refute the use of plasmapheresis for myasthenia gravis, pediatric autoimmune neuropsychiatric disorders associated with streptococcus infection, and Sydenham chorea.